Ability of gingival crevicular fluid volume, E‐cadherin, and total antioxidant capacity levels for predicting outcomes of nonsurgical periodontal therapy for periodontitis patients
Journal of Periodontal Research · 2024
DOI: 10.1111/jre.13213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Periodontal Research, 2024. Verfasst von Hind R Hussein und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics, College of Dentistry, University of Baghdad, Baghdad, Iraq. Hauptthemen laut MEDLINE: Antioxidants, Periodontitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Objectives
To determine the potential of gingival crevicular fluid (GCF) volume, E‐cadherin and total antioxidant capacity (TAC) levels to predict the outcomes of nonsurgical periodontal therapy (NSPT) for periodontitis patients.
Background
NSPT is the gold‐standard treatment for periodontal pockets < 6 mm in depth, however, successful outcomes are not always guaranteed due to several factors. Periodontitis‐associated tissue destruction is evidenced by the increased level of soluble E‐cadherin and reduced antioxidants in oral fluids which could be used as predictors for success/failure of NSPT. Materials and Methods Patients with periodontitis ( n = 24) were included in this clinical trial and full‐mouth periodontal charting was recorded for each patient. GCF samples from periodontal pockets with probing pocket depth (PPD) 4–6 mm from the interproximal surfaces of anterior and premolar teeth were obtained. These sites subsequently received NSPT and were clinically re‐evaluated after 1 and 3 months. Levels of GCF E‐cadherin and TAC levels were assayed using ELISA.
Results
All clinical periodontal parameters were significantly improved 3 months after completion of NSPT. These outcomes were associated with a significant decrease in E‐cadherin levels and GCF volume, while TAC levels were significantly increased in samples obtained in follow‐up appointments. Binary regression model analysis showed that PPD, GCF volume, E‐cadherin, and TAC levels could significantly ( p < .05) predict the outcomes of NSPT. The cut‐off points for PPD, GCF volume, E‐cadherin and TAC were 5 mm, 4 × 10 −3 , 1267.97 pg/mL and 0.09 μmol/g, respectively.
Conclusion
NSPT improved clinical parameters along with increased antioxidants capacity and epithelial pocket lining integrity. Discrimination of favorable/unfavorable responsiveness of periodontally diseased sites to NSPT could be possible by using GCF volume, PPD, E‐cadherin and TAC level assessments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontics, College of Dentistry, University of Baghdad, Baghdad, Iraq.
- Al-Noor Dental Center, Ministry of Health, Baghdad, Iraq.
- School of Dentistry, University of Birmingham, Birmingham, UK.
- Faculty of Dentistry, Sir John Walsh Research Institute, University of Otago, Dunedin, New Zealand.
ORCID-Profile: Mike R Milward
Zitieren
APA
Hussein, H. R., Abdulkareem, A. A., Milward, M. R., & Cooper, P. R. (2024). Ability of gingival crevicular fluid volume, E‐cadherin, and total antioxidant capacity levels for predicting outcomes of nonsurgical periodontal therapy for periodontitis patients. Journal of Periodontal Research. https://doi.org/10.1111/jre.13213
Vancouver
Hussein HR, Abdulkareem AA, Milward MR, Cooper PR. Ability of gingival crevicular fluid volume, E‐cadherin, and total antioxidant capacity levels for predicting outcomes of nonsurgical periodontal therapy for periodontitis patients. Journal of Periodontal Research. 2024. doi:10.1111/jre.13213
BibTeX
@article{Hussein2024,
author = {Hussein, Hind R and Abdulkareem, Ali A and Milward, Mike R and Cooper, Paul R},
title = {Ability of gingival crevicular fluid volume, E‐cadherin, and total antioxidant capacity levels for predicting outcomes of nonsurgical periodontal therapy for periodontitis patients},
journal = {Journal of Periodontal Research},
year = {2024},
doi = {10.1111/jre.13213}
}
EUVIMED